South Korea · Delayed Price · Currency is KRW Ildong Pharmaceutical Company Description
Ildong Pharmaceutical Co., Ltd. develops, manufactures, and sells pharmaceutical products in South Korea.
The company offers active lactic acid bacterial and anti-diarrheal agents, antibiotics, antifungal and antiviral products, anti-histamine drugs, antineoplastic agents, and NSAIDs and analgesics, as well as vitamins, minerals, and nutrients; and drugs for blood circulation, cardiovascular and central nervous system, dental, endocrine and metabolic system, gastrointestinal system, respiratory system, topical preparation, and urogenital system applications.
It also provides raw material drugs; health foods and foods; cosmetics; medical devices for scar treatment; and other drugs for treating thick wounds, osteoarthritis, periarthritis of shoulder, and artificial tears, as well as feminine cleanser products.
In addition, the company manages licenses and provides contract manufacturing services. It also exports its products to approximately 20 countries worldwide.
Ildong Pharmaceutical Co., Ltd. a strategic collaboration with Evotec SE to accelerate the development of various Ildong’s proprietary projects through access to Evotec’s INDiGO platform.
The company was founded in 1941 and is headquartered in Seoul, South Korea.
| Country | South Korea |
| Founded | 1941 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| Employees | 1,033 |
| CEO | Yun Paul Woongsup |
Contact Details
Address: 2, Baumoe-ro 27-gil Seoul, 137-130 South Korea | |
| Phone | 82 2 526 3114 |
| Website | ildong.com |
Stock Details
| Ticker Symbol | 249420 |
| Exchange | Korea Stock Exchange |
| Stock Type | Common Stock |
| Fiscal Year | January - December |
| Reporting Currency | KRW |
| ISIN Number | KR7249420001 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Yun Paul Woongsup | Chief Executive Officer |